[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.94.5. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Quick Uptakes
February 24, 1999

New Recommendations for CHF

Author Affiliations
 

Not Available

Not Available

JAMA. 1999;281(8):694. doi:10.1001/jama.281.8.694-JQU90000-2-1

Most patients with congestive heart failure (CHF) should receive a four-drug regimen, according to new recommendations from a panel of more than 150 leading CHF experts.

The recommendations, issued on behalf of the nonprofit Advisory Council To Improve Outcomes Nationwide in Heart Failure (ACTION HF), are based on an 18-month review of available data on the treatment of CHF. The expert panel concluded that most patients should receive digitalis and diuretics in combination with angiotensin-converting enzyme (ACE) inhibitors and β-blockers. Currently, about 40% of CHF patients receive ACE inhibitors and just 5% receive β-blockers, the panel noted.

First Page Preview View Large
First page PDF preview
First page PDF preview
×